Abstract
Background Cytokines are actively involved in the regulation of the inflammatory and immune responses and play crucial importance for the outcome of spinal cord injury (SCI). Considering the importance of examining more objective and representative indicators of the patient’s condition is still required to reveal the fundamental patterns of abovementioned posttraumatic processes, including identification of changes in the expression of cytokines.
Methods We performed a dynamic (3, 7 and 14 dpi) extended multiplex analysis of cytokine profiles in both CSF and blood serum of SCI patients with baseline American Spinal Injury Association Impairment Scale grades of A.
Results The data obtained showed a large elevation of IL-6 (>58 fold) in CSF and IFN-γ (>14 fold) in blood serum at 3 dpi with a downward trend as the post-traumatic period increases. The level of cytokine CCL26 was significantly elevated both CSF and blood serum at 3 days post-SCI while other cytokines did not show the same trend in the different biosamples.
Conclusions The dynamic changes in cytokine levels observed in our study can explore the relationships with SCI region and injury severity, paving the way for a better understanding of the pathophysiology of SCI and potentially more targeted and personalized therapeutic interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by the subsidy allocated to Kazan Federal University for the state assign-ment № FZSM-2023-0011 in the sphere of scientific activities. This paper has been supported by the Kazan Federal University Strategic Academic Leadership Program (PRIORITY-2030).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Kazan Federal University Lo-cal Ethical Committee (Protocol No. 3, 23 March 2017). Written informed consent was obtained from each subject before CSF and blood serum samples were obtained.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes